Literature DB >> 11186397

Internal fixation or arthroplasty for displaced cervical hip fractures in the elderly: a randomised controlled trial of 208 patients.

M J Parker1, G A Pryor.   

Abstract

208 patients aged over 70 years with a displaced cervical hip fracture were admitted to a prospective randomised trial of internal fixation using 3 parallel cannulated screws or an uncemented Austin Moore hemiarthroplasty. All surviving patients were followed for a minimum of 3 years. Functional assessment of survivors at 1, 2 and 3 years from injury showed no significant difference between groups. Patients treated by the fixation had a marginally lower mortality rate. Other outcomes which favoured internal fixation were a lower risk of wound infection, reduced length of surgery (22 minutes versus 47 minutes), lower operative blood loss (23 mL versus 172 mL), and lower transfusion requirements (4/102 patients versus 18/106). However, internal fixation had a significantly greater re-admission rate (24/102 versus 7/106) and re-operation rate. Following internal fixation, 44 re-operations were required in 36 patients, while re-operation was required in only 4 patients treated with arthroplasty. The results of this randomised trial indicate that both procedures produce comparable final functional outcomes for the survivors.

Entities:  

Mesh:

Year:  2000        PMID: 11186397     DOI: 10.1080/000164700317381090

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  16 in total

1.  [Treatment of intracapsular fractures of the femoral neck with a biaxial proximal femoral nail].

Authors:  P Visna; E Beitl; R Hart; I Cizmar; J Pilny; Z Smidl
Journal:  Unfallchirurg       Date:  2008-05       Impact factor: 1.000

2.  Factors affecting mortality after hip fracture surgery: a retrospective analysis of 578 patients.

Authors:  Kerem Bilsel; Mehmet Erdil; Deniz Gulabi; Mehmet Elmadag; Omer Cengiz; Cengiz Sen
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-10-16

3.  Cemented bipolar hemiarthroplasty with a cerclage cable technique for unstable intertrochanteric hip fractures in elderly patients.

Authors:  Mostafa Abdelkhalek; Ayman M Ali; Mohamed Abdelwahab
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-06-06

4.  The four-year functional result after a displaced subcapital hip fracture treated with three different surgical options.

Authors:  George Mouzopoulos; Michalis Stamatakos; Helen Arabatzi; George Vasiliadis; George Batanis; Anastasia Tsembeli; Mathaios Tzurbakis; Michalis Safioleas
Journal:  Int Orthop       Date:  2007-03-13       Impact factor: 3.075

5.  Functional outcomes and mortality vary among different types of hip fractures: a function of patient characteristics.

Authors:  Roger Cornwall; Marvin S Gilbert; Kenneth J Koval; Elton Strauss; Albert L Siu
Journal:  Clin Orthop Relat Res       Date:  2004-08       Impact factor: 4.176

6.  Treatment of the displaced femoral neck fracture, as reflected in Acta Orthopaedica Scandinavica.

Authors:  Rolf Onnerfält
Journal:  Acta Orthop       Date:  2010-02       Impact factor: 3.717

7.  [The minimally-invasive screw osteosynthesis of the medial femoral neck fracture in the very old. A prospective clinical study].

Authors:  M Galla; P Lobenhoffer
Journal:  Unfallchirurg       Date:  2004-05       Impact factor: 1.000

Review 8.  Multiple cannulated screws vs. dynamic hip screws for femoral neck fractures : A meta-analysis.

Authors:  Lei Lei Zhang; Ying Zhang; Xianghao Ma; Youwen Liu
Journal:  Orthopade       Date:  2017-11       Impact factor: 1.087

9.  Targon Femoral Neck for femoral-neck fracture fixation: lessons learnt from a series of one hundred and thirty five consecutive cases.

Authors:  Roland Biber; Matthias Brem; Hermann Josef Bail
Journal:  Int Orthop       Date:  2013-11-23       Impact factor: 3.075

10.  Prosthetic replacement in femoral neck fracture in the elderly: results and review of the literature.

Authors:  S K S Marya; R Thukral; Chandeep Singh
Journal:  Indian J Orthop       Date:  2008-01       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.